Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1937]
News [3134]
Articles [127]
Editorials [3]
Conferences [120]
elearning [13]
Blinatumomab has promising effect on hard-to-treat, rare acute lymphoblastic...
Prof Giovanni Martinelli - University of Bologna, Bologna, Italy
Blinatumomab has promising effect on hard-to-treat, rare acute lymphoblastic leukaemia subtype ( Prof Giovanni Martinelli - University of Bologna, Bologna, Italy )
6 Dec 2015
Rituximab plus chemotherapy improves outcomes in acute lymphoblastic leukaemia
Dr Sébastien Maury - Hôpital Henri Mondor, Créteil, France
Rituximab plus chemotherapy improves outcomes in acute lymphoblastic leukaemia ( Dr Sébastien Maury - Hôpital Henri Mondor, Créteil, France )
6 Dec 2015
First all-oral treatment for relapsed and treatment-resistant multiple myeloma
Prof Philippe Moreau - University of Nantes, Nantes, France
First all-oral treatment for relapsed and treatment-resistant multiple myeloma ( Prof Philippe Moreau - University of Nantes, Nantes, France )
6 Dec 2015
Experimental oral therapy for high-risk CLL shows promise
Prof Stephan Stilgenbauer - University of Ulm, Ulm, Germany
Experimental oral therapy for high-risk CLL shows promise ( Prof Stephan Stilgenbauer - University of Ulm, Ulm, Germany )
6 Dec 2015
Ibrutinib to treat elderly patients with chronic lymphocytic leukaemia
Dr Alessandra Tedeschi - Azienda Ospedaliera Niguarda Cà Granda Milano, Milano...
Ibrutinib to treat elderly patients with chronic lymphocytic leukaemia ( Dr Alessandra Tedeschi - Azienda Ospedaliera Niguarda Cà Granda Milano, Milano, Italy )
6 Dec 2015
Idelalisib combination therapy in relapsed or treatment-resistant CLL better...
Dr Andrew Zelenetz - Memorial Sloan Kettering Cancer Center, New York, USA
Idelalisib combination therapy in relapsed or treatment-resistant CLL better than standard regimen ( Dr Andrew Zelenetz - Memorial Sloan Kettering Cancer Center, New York, USA )
6 Dec 2015
ASH 2015: Novel combination approaches for multiple myeloma
Prof Marivi Mateos, Prof Sagar Lonial, Dr Torben Plesner, Prof Meletios...
ASH 2015: Novel combination approaches for multiple myeloma ( Prof Marivi Mateos, Prof Sagar Lonial, Dr Torben Plesner, Prof Meletios Dimopoulos )
6 Dec 2015
ASH 2015: Ibrutinib as first-line treatment for chronic lymphocytic leukaemia
Prof John Gribben and Prof Stilgenbauer
ASH 2015: Ibrutinib as first-line treatment for chronic lymphocytic leukaemia ( Prof John Gribben and Prof Stilgenbauer )
6 Dec 2015
ASH 2015: New targeted therapies for haematological malignancies
Dr Robert Hromas - University of Florida, Gainesville, USA
ASH 2015: New targeted therapies for haematological malignancies ( Dr Robert Hromas - University of Florida, Gainesville, USA )
6 Dec 2015
Using epigenetics to manipulate cancer cells
Dr Stephen Nimer - Sylvester Comprehensive Cancer, Miami, USA
Using epigenetics to manipulate cancer cells ( Dr Stephen Nimer - Sylvester Comprehensive Cancer, Miami, USA )
6 Dec 2015
Overcoming the barriers of the P53 dysfunction to cure blood cancers
Dr Guillermina Lozano - MD Anderson Cancer Center, Houston, USA
Overcoming the barriers of the P53 dysfunction to cure blood cancers ( Dr Guillermina Lozano - MD Anderson Cancer Center, Houston, USA )
6 Dec 2015
Exciting new immunosuppressive therapy treatment for aplastic anaemia
Dr Danielle Townsley - George Washington University School of Medicine...
Exciting new immunosuppressive therapy treatment for aplastic anaemia ( Dr Danielle Townsley - George Washington University School of Medicine, Washington, USA )
6 Dec 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation